| Cash Flow | 2025-09-30 |
|---|---|
| Net income | -736 |
| Depreciation expense | 32,827 |
| Amortization of acquired lease intangible assets | 10,582 |
| Amortization of above market leases, net | 505 |
| Amortization of debt issuance costs and other | 1,672 |
| Stock-based compensation expense | 3,086 |
| Capitalized preacquisition and other costs charged to expense | 58 |
| (gain) loss on sale of investment properties | 1,859 |
| Impairment of investment property | 6,281 |
| Equity loss from unconsolidated joint venture | 123 |
| Other | -94 |
| Tenant receivables | 522 |
| Deferred assets | 1,094 |
| Other assets and liabilities | 1,830 |
| Accounts payable and accrued expenses | 2,602 |
| Security deposits | 188 |
| Net cash provided by operating activities | 51,977 |
| Purchase of land, buildings, and other tangible and intangible assets and liabilities | 70,468 |
| Net proceeds from sale of investment property | 12,695 |
| Distribution of capital from unconsolidated joint venture | 97 |
| Escrow deposits for purchase of properties | -290 |
| Advances made to related parties | -97 |
| Capital expenditures on existing real estate investments | 7,860 |
| Leasing commissions | 1,809 |
| Net cash used in investing activities | -67,152 |
| Repayment of notes payable | 13,268 |
| Proceeds from credit facility | 115,400 |
| Repayment of credit facility | 40,300 |
| Dividends paid to common stockholders, and op unit and ltip unit holders | 41,393 |
| Dividends paid to preferred stockholders | 4,366 |
| Net cash provided by financing activities | 16,073 |
| Net (decrease) increase in cash and cash equivalents and restricted cash | 898 |
| Cash and cash equivalents at beginning of period | 8,942 |
| Cash and cash equivalents at end of period | 9,840 |
Global Medical REIT Inc. (GMRE-PA)
Global Medical REIT Inc. (GMRE-PA)